These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. [The circulatory system in endogenous depressive syndromes and during treatment with tricyclic antidepressive agents]. Bogdanowicz E Psychiatr Pol; 1973; 7(6):665-71. PubMed ID: 4773054 [No Abstract] [Full Text] [Related]
50. [Has new antidepressive agents changed the clinical conditions of depressive diseases?]. Miyaoka H Seishin Shinkeigaku Zasshi; 2004; 106(7):933-5. PubMed ID: 15478637 [No Abstract] [Full Text] [Related]
52. An interim overview of the safety and tolerability of paroxetine. Dunbar GC Acta Psychiatr Scand Suppl; 1989; 350():135-7. PubMed ID: 2530767 [No Abstract] [Full Text] [Related]
53. Effects of antidepressants on cardiac function. Burgess CD Acta Psychiatr Scand Suppl; 1981; 290():370-9. PubMed ID: 6939319 [TBL] [Abstract][Full Text] [Related]
54. [Hematologic effects associated with taking indalpine. Cooperative study by French drug surveillance centers]. Castot A; Efthymiou ML Therapie; 1985; 40(5):337-41. PubMed ID: 4095692 [No Abstract] [Full Text] [Related]
55. The cardiovascular toxicity of antidepressants. Warrington SJ Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():63-70. PubMed ID: 3063746 [No Abstract] [Full Text] [Related]